病院用ロボット市場シェア分析、業界動向と統計、成長予測 2026-2031年

病院用ロボット市場規模は、2025年に22億6,000万米ドル、2026年に25億6,000万米ドル、そして2031年には50億1,000万米ドルに達すると予測されており、2026年から2031年にかけて年平均成長率（CAGR）14.42%で成長する見込みです。

設備投資予算が逼迫しているにもかかわらず、手術、物流、リハビリテーションプラットフォームの調達は着実に継続しており、自動化が試験的なプロジェクト段階から中核的な臨床インフラへと移行したことを示しています。需要は、高齢化に伴う手術件数の増加、人件費の上昇につながる看護師や技術者の深刻な不足、そして単位活動ではなく成果に基づく報酬制度の拡大という3つの構造的要因と合致しています。ベンダー各社は、設置面積の縮小、使用量ベースの料金体系、そして病院経営陣のリスク評価に対応する組み込み型サイバーセキュリティ制御といったソリューションでこれに対応しています。同様に重要なのは、成熟した5G接続が都市部以外の地域でも安全な遠隔操作を可能にし、ロボットのサービス提供範囲をサービスが行き届いていない地域にまで拡大することで、病院用ロボット市場を拡大することであります。

レポートの主要ポイント

• 製品タイプ別に見ると、手術用ロボットが2025年の病院用ロボット市場シェアの59.12%を占め、市場を牽引しました。リハビリテーション用ロボットは、2031年まで年平均成長率（CAGR）15.06%で拡大すると予測されています。
• 用途別に見ると、手術分野が2025年の収益の47.38%を占め、リハビリテーション分野は2031年まで年平均成長率15.67%で成長しています。
• コンポーネント別に見ると、ハードウェアは2025年の病院用ロボット市場規模の68.21%を占め、ソフトウェアは2026年から2031年にかけて年平均成長率14.96%で成長すると予測されています。
• エンドユーザー別に見ると、総合病院は2025年に46.03%のシェアを占め、リハビリテーションセンターは2031年までに年平均成長率（CAGR）15.86%の成長が見込まれています。
• 地域別に見ると、北米は2025年に収益の38.83%を占め、アジア太平洋地域は2031年までに年平均成長率16.14%を記録すると予測されています。

Hospital Robots Market Analysis by Mordor Intelligence

The Hospital Robots Market size is projected to be USD 2.26 billion in 2025, USD 2.56 billion in 2026, and reach USD 5.01 billion by 2031, growing at a CAGR of 14.42% from 2026 to 2031.

Steady procurement of surgical, logistics, and rehabilitation platforms continues despite tighter capital budgets, confirming that automation has moved from pilot projects to core clinical infrastructure. Demand aligns with three structural factors: rising procedure volumes among aging populations, widening nurse and technician shortages that lift wage bills, and proliferating regulatory incentives that reimburse value-based outcomes rather than unit activity. Vendors respond with smaller footprints, usage-based pricing, and embedded cybersecurity controls that answer hospital boards’ risk assessments. Equally important, maturing 5G connectivity now supports safe teleoperation beyond metropolitan hubs, extending robotics coverage to underserved regions and thereby enlarging the hospital robots market.

Key Report Takeaways

• By product type, surgical robots led with a 59.12% hospital robots market share in 2025; rehabilitation robots are forecast to expand at a 15.06% CAGR to 2031.
• By application, surgery commanded 47.38% of revenue in 2025, while rehabilitation is advancing at a 15.67% CAGR through 2031.
• By component, hardware accounted for 68.21% of the hospital robots market size in 2025, and software is projected to post a 14.96% CAGR over 2026-2031.
• By end user, general hospitals held 46.03% share in 2025, whereas rehabilitation centers are poised for 15.86% CAGR growth by 2031.
• By geography, North America captured 38.83% revenue in 2025; Asia-Pacific is projected to record a 16.14% CAGR to 2031.

Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.

Global Hospital Robots Market Trends and Insights

Heightened Post-Pandemic Focus on Infection Control

Hospitals maintain UV-C disinfection budgets because automated cycles reduce pathogen loads in operating rooms and ICUs within minutes, trimming costly readmissions tied to surgical-site infections.[1]LightStrike+ has completed over 35 million cycles and provides ISO 15883-compliant audit logs that simplify Joint Commission reviews. Facilities that adopted the platform during COVID-19 report persistent usage as bundled payments penalize hospital-acquired infections. The FDA 510(k) clearance reassures biomedical engineers that routine maintenance fits existing protocols.[2]As capital budgets rebound, disinfection robots remain a visible first step toward wider hospital robots market deployment.

Rapid Adoption of Minimally Invasive Surgery

Intuitive Surgical’s da Vinci 5 adds force feedback and enhanced 3D vision, addressing earlier tactile gaps and enabling newly approved cardiac indications in 2026. Peer-reviewed studies still show mixed cost-outcome profiles, but faster patient recovery supports value-based contracts. Orthopedic programs mirror the trend; Stryker’s Mako platform surpassed 1.5 million knee and hip procedures in 2025, confirming scale potential when pathways standardize workflows.[3] Together, these advances sustain double-digit growth for the hospital robots market as surgeons seek precision and patients demand smaller incisions.

Shortage of Clinical Staff and Rising Labor Costs

Vacancy rates above 15% in U.S. nursing units shift hospital priorities toward autonomous logistics. Moxi completed more than 1.25 million deliveries by late 2025, removing low-value trips and returning time to bedside care. OhmniLabs telepresence devices extend dietitians’ reach across multiple floors, cutting travel time by up to 40 minutes per consult. As wage pressure climbs, executives model three-year paybacks that now encompass service robots, propelling the broader hospital robots market.

Integration of 5G-Enabled Telerobotics

A multicenter Japanese trial maintained sub-10 ms latency during 50 km remote surgeries, meeting safety thresholds and demonstrating rural feasibility. China’s policy push places surgical robots into tier-2 cities, while regulators refine cross-border licensure standards. The capability widens specialist access without relocating clinicians, making 5G a catalyst for hospital robots market penetration beyond flagship institutions.

High Capital Expenditure and ROI Concerns

Acquisition prices ranging from USD 1 million to USD 2.5 million deter hospitals operating on single-digit margins. A Baird survey found 77% of executives rank ROI validation as the top purchasing criterion, and 71% still rely on retained earnings for funding. Usage-based leases from Intuitive Surgical and Stryker reduce upfront cash but shift utilization risk to vendors. Absent distinct DRG codes, facilities bundle robotic costs into existing reimbursements, favoring high-volume centers and limiting near-term hospital robots market adoption among mid-tier providers.

Complex Regulatory and Credentialing Pathways

FDA Section 524B requires a software bill of materials and vulnerability management plans, elongating submission files and boosting compliance expenses. Europe’s Medical Device Regulation imposes additional clinical evidence and post-market surveillance, extending launch timelines by 12-18 months. Surgeon credentialing remains fragmented because specialty societies have yet to mandate uniform curricula. These layers collectively delay commercialization and slow hospital robots market growth.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Product Type: Surgical Dominance Meets Rehabilitation Momentum

Surgical robots contributed 59.12% revenue in 2025, benefiting from an installed base of more than 8,000 da Vinci systems and accelerating orthopedic adoption driven by Mako’s 1.5 million procedures. Rehabilitation platforms are on track for 15.06% CAGR through 2031, fueled by aging demographics and payers that recognize cost savings from robotic gait therapy. This pocket outpaces the overall hospital robots market CAGR as stroke and spinal cord injury prevalence rise.

Price competition intensifies as Johnson & Johnson’s Ottava table-integrated design enters FDA review, promising reduced footprint costs. Service and logistics units such as Moxi and Aethon’s TUG diversify revenue by automating specimen, linen, and meal transport. Disinfection and telepresence robots remain niche yet strategic, anchoring infection prevention and remote consultation programs that feed the evolving hospital robots market.

By Application: Surgery Leads Rehabilitation Accelerates

Surgery retained 47.38% share in 2025 because robotic prostatectomy, hysterectomy, and colorectal resections command premium reimbursement. Rehabilitation, projected at 15.67% CAGR, gains traction as insurers accept outpatient exoskeleton therapy and home use following ReWalk 7 clearance in 2025.

Logistics-delivery volumes rise as pharmacy runs shift to Moxi, freeing nursing time and reducing medication turnaround intervals. Cleaning deployments persist post-pandemic as LightStrike+ supports infection-control metrics. Remote engagement remains modest yet expands coverage for dietetic and specialist consults. Together, these indications broaden the hospital robots market beyond the operating suite.

By Component: Hardware Dominates Software Gains

Hardware held 68.21% of 2025 revenue because robotic arms, sensors, and consoles carry high invoice prices, locking in the largest share of the hospital robots market size. Software grows at 14.96% CAGR as AI-enabled planning and predictive maintenance migrate value toward subscription models, generating recurring income streams.

Intuitive Surgical’s cloud analytics forecast instrument wear, and Stryker’s planning algorithms optimize implant placement, exemplifying how software deepens customer lock-in. Services bundles covering installation, training, and 24-hour maintenance underpin uptime-critical programs, reinforcing vendor relationships and smoothing annual budgets.

By End User: General Hospitals Anchor Rehabilitation Centers Surge

General hospitals owned 46.03% share in 2025 by virtue of broad service lines and multi-specialty robotics programs. Rehabilitation centers, however, will post a 15.86% CAGR, reflecting demand for robotic gait therapy in post-acute pathways. Specialty hospitals, particularly orthopedic centers, compress payback periods by concentrating joint replacements on dedicated Mako and Rosa systems.

Ambulatory surgical centers adopt compact or handheld robots such as Mako RPS, cleared in 2026, enabling partial knee arthroplasty without full console investments. Other facilities, including long-term care providers, pilot telepresence and portable rehab devices, are expanding the total addressable hospital robots market.

Complete Report Scope:

Geography Analysis

North America contributed 38.83% revenue in 2025, underpinned by favorable reimbursement and a deep installed base. Saturation appears in large urban systems, so growth tilts toward ambulatory sites and community hospitals upgrading to compact systems. Canada trails the United States because provincial budgets limit capital purchases, while Mexico sees sporadic private installations.

Asia-Pacific advances at 16.14% CAGR through 2031, supported by China’s provincial grants that install surgical robots in tier-2 cities and Japan’s 5G teleoperation rollouts that bridge rural gaps. India’s private groups invest in da Vinci and Mako units to capture inbound medical tourism, lifting hospital robots market penetration.

Europe grows steadily despite longer approval cycles under MDR. Germany, France, and the United Kingdom lead deployments, whereas Southern and Eastern markets adopt at a slower rate. The Middle East and South America remain in the early stages but display strategic pilots in Gulf Cooperation Council hospitals and Brazilian academic centers that prove clinical worth and inform future scaling.

Competitive Landscape

Intuitive Surgical retains a hold of the surgical segment by leveraging over 8,000 installed da Vinci systems and continuous software upgrades. Orthopedic leaders Stryker, Zimmer Biomet, and Smith & Nephew erode share by offering differentiated joint-specific robots with lower acquisition costs and strong clinical pathways.

Service-robot specialists Diligent Robotics, Aethon, and Swisslog implement high-volume logistics programs, while rehabilitation innovators such as ReWalk and Ekso Bionics target expanding neuro-rehab populations. Johnson & Johnson positions Ottava for entry in 2027 pending FDA clearance, banking on a table-integrated design that minimizes footprint and accelerates OR turnarounds. Early adopters prioritize platforms that exhibit secure connectivity per FDA Section 524B and IEC 62443 standards, after Cynerio revealed critical vulnerabilities in TUG units in 2024.

Subscription pricing, modular upgrades, and AI-enabled decision support differentiate vendors amid tightening budgets. Those providing quantifiable outcome data, seamless EHR integration, and transparent total cost of ownership will consolidate gains as the hospital robotics market matures.

Recent Industry Developments

• February 2026: Stryker received FDA clearance for Mako RPS handheld robotics for partial knee arthroplasty.
• January 2026: Johnson & Johnson submitted a de novo FDA application for Ottava, a table-integrated 4-arm surgical robot aimed at upper abdominal procedures.
• January 2026: Intuitive Surgical secured FDA approval for cardiac applications on da Vinci 5, extending reach into mitral valve repair.
• October 2025: Diligent Robotics launched Moxi 2.0 with NVIDIA IGX Thor compute, targeting deployment of 15 units per site by 2030.

List of Companies Covered in this Report:

• ABB Ltd.
• Aethon Inc. (ST Engineering)
• Cyberdyne
• Diligent Robotics Inc.
• Ekso Bionics
• F&P Robotics AG
• Intuitive Surgical
• Johnson & Johnson
• KUKA AG
• Medtronic
• Omnicell
• Panasonic Corporation
• ReWalk Robotics
• Siemens Healthineers
• Smiths Group
• Stryker
• Swisslog Healthcare (KUKA AG)
• Xenex Disinfection Services Inc.
• Yaskawa Electric Corp.
• Zimmer Biomet

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Table of Contents

1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Heightened Post-Pandemic Focus on Infection Control
4.2.2 Rapid Adoption of Minimally-Invasive Surgery
4.2.3 Shortage of Clinical Staff & Rising Labor Costs
4.2.4 Integration of 5G-Enabled Telerobotics
4.2.5 Hospital-At-Home Logistics Pilots Using Mobile Robots
4.2.6 Growing Emphasis on Precision Medicine and Personalized Surgical Planning
4.3 Market Restraints
4.3.1 High Capital Expenditure & ROI Concerns
4.3.2 Complex Regulatory & Credentialing Pathways
4.3.3 Cyber-Physical Security Vulnerabilities
4.3.4 Shortage of Skilled Robotics Technicians & Maintenance Support
4.4 Regulatory Landscape
4.5 Technological Outlook
4.6 Porter’s Five Forces Analysis
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitutes
4.6.5 Competitive Rivalry

5 Market Size & Growth Forecasts
5.1 By Product Type
5.1.1 Surgical Robots
5.1.2 Rehabilitation Robots
5.1.3 Service & Logistics Robots
5.1.4 Disinfection Robots
5.1.5 Telepresence Robots
5.1.6 Pharmacy Automation Robots
5.2 By Application
5.2.1 Surgery
5.2.2 Rehabilitation
5.2.3 Logistics & Supply Delivery
5.2.4 Cleaning & Disinfection
5.2.5 Patient Engagement & Monitoring
5.2.6 Medication Dispensing
5.3 By Component
5.3.1 Hardware
5.3.2 Software
5.3.3 Services
5.4 By End User
5.4.1 General Hospitals
5.4.2 Specialty Hospitals
5.4.3 Ambulatory Surgical Centers
5.4.4 Rehabilitation Centers
5.4.5 Other End Users
5.5 By Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East & Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East & Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America

6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global Level Overview, Market-level Overview, Core Segments, Financials, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
6.3.1 ABB Ltd.
6.3.2 Aethon Inc. (ST Engineering)
6.3.3 Cyberdyne Inc.
6.3.4 Diligent Robotics Inc.
6.3.5 Ekso Bionics Holdings Inc.
6.3.6 F&P Robotics AG
6.3.7 Intuitive Surgical Inc.
6.3.8 Johnson & Johnson
6.3.9 KUKA AG
6.3.10 Medtronic
6.3.11 Omnicell Inc.
6.3.12 Panasonic Corporation
6.3.13 ReWalk Robotics Ltd.
6.3.14 Siemens Healthineers AG
6.3.15 Smith & Nephew plc
6.3.16 Stryker Corporation
6.3.17 Swisslog Healthcare (KUKA AG)
6.3.18 Xenex Disinfection Services Inc.
6.3.19 Yaskawa Electric Corp.
6.3.20 Zimmer Biomet Holdings Inc.

7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-need Assessment

---

---